Psychedelics-Assisted Therapy

Blackhawk Growth Corp. (OTCMKTS: BLRZF), an investment holding company focused on acquiring and developing high-growth companies in the health, cannabis and psychedelics sectors in the US and Canada, announced it intends to complete a spin-out transaction of its wholly-owned subsidiaries MindBio...

Crypto Billionaire Brock Pierce Joins Psychedelic Venture Fund, Says 'Potential Reward Is Immeasurable' Benzinga was the first to report that Brock Pierce, the crypto billionaire, economist and philanthropist serving as chairman of the Bitcoin Foundation, has joined Jeremy Gardner’s...

Mental health care company Numinus Wellness (OTCQX: NUMIF) is re-launching its "Psychedelic Therapy Frontiers" podcast series dedicated to exploring the psychedelics renaissance and cultivating mind, body and spiritual health with new hosts, expanded topics and fresh branding.  The...

15 Global Psychedelics Executives To Keep An Eye On In 2022 As the global psychedelics industry booms, with companies going public, major financing efforts being announced, and celebrities and big investors getting on board, Benzinga has decided to put together a list of some of the top executives...

Clinical-stage biopharma company Incannex Healthcare Ltd. (NASDAQ: IXHL) shared its quarterly activities report and appendix 4C for the period ended 30 September 2022, noticeably applying for several U.S. FDA approvals regarding its cannabinoid pharmaceutical products and psychedelic...

As of January 2023, Canada’s 4th largest province will be the first to offer supervised treatments involving psychedelic substances such as psilocybin, MDMA, LSD, mescaline, DMT and ketamine to those among its 4.5 million population suffering from mental health disorders. The decision...